Search

everythinglearnresearchcommunity

for

Search:↓

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hair restoration surgery has advanced, focusing on natural results and may improve further with new techniques and therapies.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Finasteride may cause cataracts and floppy-iris syndrome.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Finasteride use can cause depression-like behavior in male rats.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Finasteride use doesn't cause sexual dysfunction in men with hair loss.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Some skin diseases and their treatments can negatively affect male fertility.

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Father's finasteride use may affect son's fertility and testicular function.